Staphylococcus aureus Cell Wall Stress Stimulon Gene -lacZ Fusion Strains: Potential for Use in Screening for Cell Wall-Active Antimicrobials

Antimicrobial Agents and Chemotherapy
2008.0

Abstract

lacZ fusion strains were constructed using the promoters of five cell wall stress stimulon genes: pbp2, tcaA, vraSR, sgtB, and lytR. All fusion strains were induced only in the presence of cell wall-active antibiotics, suggesting the potential of these strains for use in high-throughput screening for new cell wall-active agents.

Knowledge Graph

Similar Paper

Staphylococcus aureus Cell Wall Stress Stimulon Gene -lacZ Fusion Strains: Potential for Use in Screening for Cell Wall-Active Antimicrobials
Antimicrobial Agents and Chemotherapy 2008.0
Method for Screening Compounds That Influence Virulence Gene Expression in Staphylococcus aureus
Antimicrobial Agents and Chemotherapy 2010.0
Functional Characterization of TcaA: Minimal Requirement for Teicoplanin Susceptibility and Role in Caenorhabditis elegans Virulence
Antimicrobial Agents and Chemotherapy 2007.0
A mec A -Negative Strain of Methicillin-Resistant S taphylococcus aureus with High-Level β-Lactam Resistance Contains Mutations in Three Genes
Antimicrobial Agents and Chemotherapy 2010.0
Identification and Phenotypic Characterization of a β-Lactam-Dependent, Methicillin-Resistant Staphylococcus aureus Strain
Antimicrobial Agents and Chemotherapy 2007.0
VanA-Type Vancomycin-ResistantStaphylococcus aureus
Antimicrobial Agents and Chemotherapy 2009.0
Altered Growth, Pigmentation, and Antimicrobial Susceptibility Properties of Staphylococcus aureus Due to Loss of the Major Cold Shock Gene cspB
Antimicrobial Agents and Chemotherapy 2010.0
Staphylococcus aureus PBP4 Is Essential for β-Lactam Resistance in Community-Acquired Methicillin-Resistant Strains
Antimicrobial Agents and Chemotherapy 2008.0
2-Phenyl-5,6-dihydro-2H-thieno[3,2-c]pyrazol-3-ol derivatives as new inhibitors of bacterial cell wall biosynthesis
Bioorganic & Medicinal Chemistry Letters 2003.0
Contribution of vraSR and graSR Point Mutations to Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus
Antimicrobial Agents and Chemotherapy 2009.0